Condition: Benign Prostatic Hyperplasia · Sponsor: Assistance Publique - Hôpitaux de Paris
The aim of the current study is to evaluate the efficacy of transperineal focal microwave ablation (TMA) of the prostate transition zone as a new treatment for lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) within a prospective single-institutional pilot study.
This description comes directly from the study's public registry record.
Nicolas BARRY DELONGCHAMPS, MD, PHD · +33 1 58 41 27 64 · nicolas.barry-delongchamps@aphp.fr
Karima MESBAHI · +33 1 58 41 12 11 · karima.mesbahi@aphp.fr
Always discuss trial participation with your own doctor first.
| Hôpital Cochin | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06212453